Michael Barbella, Managing Editor02.16.24
L&T Technology Services Limited is teaming up with NVIDIA to develop software-defined architectures for endoscopy-focused medical devices, which will enhance product image quality and scalability.
This solution is meant as an answer to the industry-wide challenges of availability, cost, and dependencies linked to custom and proprietary hardware components. The architecture is a scalable platform that supports multiple applications, providing a real-time decision-making tool for the medtech sector.
“The combination of LTTS’ expertise in medical-device development and NVIDIA’s full-stack edge AI computing platform delivers value to the medical technology industry by accelerating the development of AI-enabled, software-defined medical devices,” said Shanker Trivedi, senior vice president of Enterprise Business at NVIDIA. “This collaboration provides a complete solution for customers looking to transition to a software-defined business model via real-time AI applications.”
Developed from the ground up, the architecture boasts an image processing pipeline for noise reduction, edge and contrast enhancement, texture and color enhancement, and speckle correction. It also features AI/ML models developed for detecting, identifying, and classifying polyps—abnormal growths often found during colonoscopies. The solution also has a user-friendly interface and seamless integration of the image processing pipeline for visualization. It promises low-latency data transfer, superior image processing without performance bottlenecks, and scalability, according to L&T Technology Services.
The collaboration leverages the NVIDIA Holoscan and NVIDIA IGX Orin platforms, featuring ultra-low latency in data transfer, superior image processing, and scalability to support multiple artificial intelligence (AI)-enabled applications. This helps ensure enhanced visualization for image processing and AI-based decision-making support, such as for polyp detection and classification.
“Our collaboration with NVIDIA helps us push the boundaries of what’s possible in medical imaging,” L&T Technology Services CEO/Managing Director Amit Chadha said. “The combination of the NVIDIA Holoscan software platform for edge AI inference and the NVIDIA IGX Orin hardware platform accelerates the development of AI-powered medical imaging solutions by enhancing image quality and real-time clinical decision-making support, making clinicians more efficient and improving patient outcomes.”
L&T Technology Services Limited (LTTS) is a listed subsidiary of Larsen & Toubro Limited focused on engineering and R&D (ER&D) services. The company offers consultancy, design, development, and testing services across the product and process development life cycle. Its customer base includes 69 Fortune 500 companies and 57 of the world’s top ER&D companies, across industrial products, medical devices, transportation, telecom and hi-tech, and the process industries. Headquartered in India, L&T Technology Services has more than 23,800 employees across 22 global design centers, 28 global sales offices, and 102 innovation labs as of Sept. 30, 2023.
This solution is meant as an answer to the industry-wide challenges of availability, cost, and dependencies linked to custom and proprietary hardware components. The architecture is a scalable platform that supports multiple applications, providing a real-time decision-making tool for the medtech sector.
“The combination of LTTS’ expertise in medical-device development and NVIDIA’s full-stack edge AI computing platform delivers value to the medical technology industry by accelerating the development of AI-enabled, software-defined medical devices,” said Shanker Trivedi, senior vice president of Enterprise Business at NVIDIA. “This collaboration provides a complete solution for customers looking to transition to a software-defined business model via real-time AI applications.”
Developed from the ground up, the architecture boasts an image processing pipeline for noise reduction, edge and contrast enhancement, texture and color enhancement, and speckle correction. It also features AI/ML models developed for detecting, identifying, and classifying polyps—abnormal growths often found during colonoscopies. The solution also has a user-friendly interface and seamless integration of the image processing pipeline for visualization. It promises low-latency data transfer, superior image processing without performance bottlenecks, and scalability, according to L&T Technology Services.
The collaboration leverages the NVIDIA Holoscan and NVIDIA IGX Orin platforms, featuring ultra-low latency in data transfer, superior image processing, and scalability to support multiple artificial intelligence (AI)-enabled applications. This helps ensure enhanced visualization for image processing and AI-based decision-making support, such as for polyp detection and classification.
“Our collaboration with NVIDIA helps us push the boundaries of what’s possible in medical imaging,” L&T Technology Services CEO/Managing Director Amit Chadha said. “The combination of the NVIDIA Holoscan software platform for edge AI inference and the NVIDIA IGX Orin hardware platform accelerates the development of AI-powered medical imaging solutions by enhancing image quality and real-time clinical decision-making support, making clinicians more efficient and improving patient outcomes.”
L&T Technology Services Limited (LTTS) is a listed subsidiary of Larsen & Toubro Limited focused on engineering and R&D (ER&D) services. The company offers consultancy, design, development, and testing services across the product and process development life cycle. Its customer base includes 69 Fortune 500 companies and 57 of the world’s top ER&D companies, across industrial products, medical devices, transportation, telecom and hi-tech, and the process industries. Headquartered in India, L&T Technology Services has more than 23,800 employees across 22 global design centers, 28 global sales offices, and 102 innovation labs as of Sept. 30, 2023.